benzolamide (pFB-ABZ), a membrane-impermeable CA inhibitor, added to the lumen also completely prevented the reduction in ⌬ Vt glu . In rabbits with chronic Cd exposure, acetazolamide prevented the glucosuria. Conclusion: Cd-MTinduced inhibition of Na-glucose cotransporter activity in the S2 segment strongly depends on luminal pH, and that an increase in pH by inhibition of luminal membrane-bound CA is useful to prevent renal Cd toxicity.
p12 Na-glucose cotransport activity as well as a late ( 1 5 min) and more prominent effect on inhibition of Na-K-ATPase activity subsequent to endocytosis of Cd-MT [2] . Since the conformation of the proteins is sometimes altered by extrinsic pH, such a change might occur in Cd-MT by alteration of extracellular pH. If this is true, Cd-induced renal toxicity might be dependent on extracellular pH. On the other hand, Cd-MT complex dissociates at very low pH into Cd 2+ and holo-MT [3] . The purpose of this study was to evaluate pH dependence of the Cd-MT-induced impairment of glucose absorption in isolated rabbit proximal tubules perfused in vitro. We also evaluated the effect of carbonic anhydrase (CA) inhibitors, which increase luminal pH by a reduction in H + secretion in vitro and in vivo.
Methods

In vitro Microperfusion
In vitro microperfusion of isolated renal tubules, developed by Burg et al. [4] , was used as modified previously [2, [5] [6] [7] . Female Japanese white rabbits weighing 1.5-2.3 kg were maintained on regular laboratory chow and allowed free access to distilled water. On the day of the experiments, animals were anesthetized with sodium pentobarbital (35 mg/kg, i.v.). The left kidney was removed, and coronal slices were made. Slices were transferred to a chilled dish containing modified Collins' solution of the following composition: 14 m M KH 2 PO 4 , 44 m M K 2 HPO 4 , 15 m M KCl, 9 m M NaHCO 3 , and 160 m M sucrose, with pH maintained at 7.4. Segments of proximal tubules (S2), with lengths ranging from 0.8 to 1.2 mm, were isolated from the medullary ray of the renal cortex by fine forceps under a stereomicroscope. Isolated tubules were transferred to the perfusion chamber mounted on an inverted microscope (IX-71, Olympus, Tokyo, Japan) and perfused in vitro at 37 ° C. Tubules were hooked up to the holding pipette, and a single-barreled perfusion pipette was inserted into the tubular lumen. Triple-barreled polyethylene tubing was inserted into the perfusion pipette to allow rapid exchange of the perfusion fluid. The perfusion rate was controlled at 10-20 nl/min by adjusting the height of the fluid reservoir, which was connected to the back end of the perfusion pipette. A flow-through bath system was used to permit rapid exchange of the bathing fluid. The bathing fluid was maintained at 37 ° C by using a warm water jacket. The flow rate of the bathing fluid ranged from 3 to 5 ml/min, allowing the bathing fluid to be exchanged within 2 s. The composition of the basal solution used in this study was as follows: 110 m M NaCl, 5 m M KCl, 25 m M NaHCO 3 , 0. 
Electrophysiological Studies
Transmural voltage (Vt) was measured by connecting a 1-M KCl agar bridge to a saturated KCl reservoir, where a calomel half-cell electrode was placed. The electrode was connected to a dual-channel electrometer (Duo 773, W.P. Instruments, New Haven, Conn., USA), and the measured voltage was recorded on a two-pen recorder (R301, Rikadenki, Tokyo, Japan). A flowingboundary 1-M KCl agar bridge connected to a calomel half-cell was placed at the outflow of the bath and served as grounding. The deflection of apical membrane voltage on abrupt elimination of glucose from the luminal fluid reflects activity of Na + -dependent glucose cotransporter in the apical membrane [8, 9] . Because we have previously confirmed that deflection of Vt on abrupt elimination of glucose from the luminal fluid ( ⌬ Vt glu ) moves in parallel with the deflection of apical membrane voltage on abrupt elimination of glucose from the luminal fluid by simultaneous recording [2] , we used ⌬ Vt glu as a parameter of the Na-glucose cotransporter activity, instead of the apical membrane voltage on abrupt elimination of glucose from the luminal fluid, in this study. The ⌬ Vt glu was measured before and 10 and 20 min after addition of Cd-MT (10 -6 g Cd/ml) to the lumen. This dose is comparable to that of chronic Cd exposure in rabbit plasma [10] .
Net Bicarbonate Transport
The concentrations of inulin and total CO 2 (assumed to be equal to that of HCO 3 ) in the perfusate and collected fluid were measured in a continuous-flow microfluorometer (Nanoflo, WPI, Sarasota, Fla., USA) [11] . Three 47-nl collections were made per period and stored under water-saturated mineral oil. Aliquots (15 nl) of each collection were analyzed for total CO 2 on the day of the experiment and for inulin on the following day using procedures specified by the manufacturer [12] . Samples of perfusate were processed similarly. The perfusion rate was generally 5-8 nl/min. The HCO 3 transport rate (JHCO 3 ) was calculated as: 
In vivo Study
Female Japanese white rabbits weighing 1.5-2.2 kg (n = 23) were used. They had free access to standard chow (CR-3, Nippon Crea, containing 0.06 g Cd/g, 7 g Cu/g, 31 g Zn/g, 392 g Fe/g, and 20.3 mg Ca/g) and distilled water until the end of the study. They were kept in the standard animal room at our medical school, with a 12-hour light/dark cycle. The temperature and humidity were maintained automatically. The rabbits were injected with CdCl 2 (0.3 mg Cd/kg, s.c. once every day) [10] and/or acetazolamide (ACZ, 2 mg/kg for low dose and 20 mg/kg for high dose, i.p. twice daily) for 8 weeks. The following four groups of rabbits were made: group 1 (n = 5), vehicle; group 2 (n = 6), CdCl 2 ; group 3 (n = 6), CdCl 2 + ACZ (2 mg/kg), and group 4 (n = 6), CdCl 2 + ACZ (20 mg/kg).
Blood and 1-day urine samples were obtained before and 4 and 8 weeks after treatment. Urine was collected using a metabolic p13 cage. Plasma and urine creatinine (Cr) were measured by a modified Jaffe's reaction using an autoanalyzer. The urine glucose concentration was measured by Glucose FA test (Wako Pure Chemicals, Osaka, Japan) using an autoanalyzer (Abbott VP, Abbott Park, Ill., USA) and expressed as the ratio to Cr concentration [10] . Cd-MT in the urine specimen was fractionized using a highperformance gel-filtration column (HLC-803A, Toyo Soda, Tokyo, Japan) and the Cd concentration was measured by flameless atomic absorption spectrophotometer (Hitachi Z 9000, Tokyo, Japan) after dilution with nitric acid [10] .
Chemicals
All solutions containing bicarbonate were bubbled with 95% O 2 , 5% CO 2 gas to an adjusted pH of 7.4. The pH of the HEPES solution was adjusted by addition of Tris. All reagents, except P -fluorobenzyl-aminobenzolamide (pFB-ABZ), were purchased from Sigma (St. Louis, Mo., USA). pFB-ABZ, a CA inhibitor impermeable to the cell membrane [12, 13] , was synthesized by the method of Tewson et al. [13] . The concentration of Cd-MT is expressed as grams of Cd per milliliter to represent the Cd concentration contained in the molecule.
Ethical Aspects
All of the experiments shown in this study were performed according to the Guidelines for Animal Research of our medical school, which thoroughly incorporated the National Guidelines for Animal Research of Japan.
Statistics
All data are expressed as means 8 SE. Statistical comparison was performed using Student's t test and ANOVA where appropriate; p values of ! 0.05 are regarded as significant.
Results
pH Dependence of Acute Effect of Luminal Cd-MT on
⌬ Vt glu First, we evaluated the effect of luminal pH on ⌬ Vt glu after luminal Cd-MT using HEPES buffer solution. As shown in figure 1 , the ⌬ Vt glu significantly decreased within 10 min after addition of Cd-MT (10 -6 g Cd/ml) when the luminal pH was 7.4 (mean ⌬ Vt glu before and 10 min after addition of Cd-MT = 2.0 8 0.1 and 0.5 8 0.1 mV, respectively; n = 17). The time needed to cause the change was slightly but significantly slower than in our previous report, in which we used bicarbonate buffer solution at the same pH [2] . When the pH of the perfusate was decreased to 6.8, the reduction in ⌬ Vt glu was significantly accelerated, whereas it was prolonged when the pH was changed to 7.7 ( fig. 1 ). The ⌬ Vt glu was maintained at a similar level for at least 20 min when Cd-MT was not added to the pH 6.8 and 7.7 solutions: ⌬ Vt glu before and 20 min after the experiments was 1.9 8 0.2 and 1.8 8 0.2 mV at pH 6.8, and 2.0 8 0.2 and 1.9 8 0.2 mV at pH 7.7, respectively; n = 4 in each.
Effect of CA Inhibitors on Cd-MT-Induced ⌬ Vt glu
Because the effect of luminal Cd-MT on ⌬ Vt glu was dependent on luminal pH, we next examined the effect of CA inhibitors, which alter luminal pH in bicarbonate buffer solution. As shown in figure 2 A, luminal Cd-MT (10 -6 g Cd/ml) almost completely suppressed ⌬ Vt glu within 10 min after addition, whereas the vehicle did not show any effects ( fig. 2 B) , confirming our previous observation [2] . We also found that a comparable concentration of native MT itself did not affect ⌬ Vt glu ( ⌬ Vt glu before and 20 min after addition of MT was 2.0 8 0.3 and 1.8 8 0.3 mV at pH 7.4, p 1 0.05). When 10 -5 M ACZ was added to the lumen, luminal administration of Cd-MT did not cause any inhibition of ⌬ Vt glu , and subsequent elimination of ACZ from the lumen caused marked inhibition of ⌬ Vt glu ( fig. 3 A) . On the other hand, administration of ACZ to the bath did not prevent the inhibitory effect of Cd-MT on ⌬ Vt glu ( fig. 3 B) .
To confirm that the observed effect of ACZ is due to inhibition of membrane-bound CA, rather than intracellular CA, we tested the effects of pFB-ABZ, an impermeable inhibitor specifically restricted in its binding to membrane-bound CA [12, 13] . Luminal pFB-ABZ (10 -5 M ) completely prevented the decrease in Cd-MT-induced ⌬ Vt glu , and this effect was reversed by elimination of the drug from the lumen ( fig. 4 A) . Once Cd-MT decreased ⌬ Vt glu , it was not recovered by addition of pFB- ABZ ( fig. 4 B) . Furthermore, addition of CA (2 mg/dl) in combination with pFB-ABZ reversed the preventive effect of pFB-ABZ against Cd-MT ( fig. 5 A) . CA alone did not affect the ⌬ Vt glu ( fig. 5 B) . When pFB-ABZ was added to the bath, it did not prevent the change in ⌬ Vt glu by luminal Cd-MT ( fig. 6 ).
Effect of Luminal CA Inhibitors on Bicarbonate
Transport JHCO 3 decreased from 68.2 8 3.4 to 33.4 8 3.7 pmol/min/mm by addition of pFB-ABZ to the lumen (n = 4, p ! 0.01), which is consistent with our previous study [12] . Luminal ACZ also reduced bicarbonate absorption from 70. (n = 4, p ! 0.01). These results indicate that pFB-ABZ and ACZ to the lumen prevented absorption of bicarbonate and consequently prevented the reduction in luminal pH in vitro.
Effect of Modulator of Cytoskeleton on Cd-MT-Induced Dysfunction of the Proximal Tubule
Since the pH-dependent effect of Cd-MT was timedependent rather than instantaneous ( fig. 1 ) , the effect might not be a direct one on the Na + -glucose cotransporter. It is possible that Cd-MT exerts an inhibitory effect after intracellular uptake of the complex. To evaluate this possibility, we examined the effect of cytoskeleton modulators. Pretreatment with colchicine (10 -5 M ) from the lumen prevented the Cd-MT-induced reduction in ⌬ Vt glu ( fig. 7 A) , whereas lumicolchicine, a biologically inactive colchicine analog, did not prevent it ( fig. 7 B) . Cytochalasin D (10 -6 M ; fig. 8 A) and Y-27632 (10 -4 M ; fig. 8 B) , an inhibitor of rho-kinase [14] , also prevented the Cd-MT-induced reduction.
In vivo Effect of ACZ in Preventing Cd-Induced Nephrotoxicity
Repeated administration of Cd caused nephrotoxicity as revealed by the increased serum Cr concentration and urinary excretion of glucose. The renal Cd toxicity represented by these data was prevented by administration of ACZ in a dose-dependent manner ( fig. 9 A, B) . The urinary Cd-MT content at the end of the study was significantly increased by co-administration with high dose of ACZ, but not by low dose ( fig. 9 C) . Body weights did not decrease in either group (data not shown).
Discussion
The present study demonstrates in rabbit proximal tubule cells that the inhibitory effect of Cd-MT on ⌬ Vt glu is pH-dependent: an increase in luminal pH prevented and a decrease in pH worsened the impairment of sodiumdependent glucose transporter activity following acute luminal exposure of Cd-MT. This is the first study showing that the impairment of sodium-dependent glucose transporter activity by luminal Cd-MT is dependent on luminal pH. We observed that the reduction in bicarbonate absorption was prevented by luminal pFB-ABZ and ACZ in this study. Because luminal pH decreased along the proximal tubule by reabsorption of bicarbonate in the filtered fluid, the reduction in bicarbonate absorption by pFB-ABZ and ACZ to the lumen inhibited the reduction in luminal pH. Therefore, a preventive effect of pFB-ABZ and ACZ on Cd-MT-induced toxicity was mediated by an increase in luminal pH. Luminal pH in the normal kidney can be changed from about 6.8 to 7.7 to adapt to the systemic acid-base status [15] . Thus, it is important to note that the prevention of the toxic effect of Cd-MT is attainable within the physiological luminal pH range in the proximal tubule.
Inhibition of CA in the cytosol and/or apical membrane of proximal tubule cells prevented the reduction in luminal pH and decreased urinary acid excretion [15] . Therefore, the prevention of the Cd-MT-induced damage by ACZ and pFB-ABZ in this study must be due to an alteration in luminal pH by these drugs. We also found that the effects of luminal ACZ and pFB-ABZ, a CA inhibitor impermeable to the cell membrane but able to affect HCO 3 -absorption in proximal tubule cells [12] , were comparable, while basolateral addition of ACZ was not effective. These results suggest that inhibition of luminal membrane-bound CA is important in preventing Cd-MT-induced damage. Among the many isoforms of CA, CA IV, XII, XIV, and XV are membrane-associated and reported to be located in the kidney, while CA XIV is not detected in the rabbit, but is detected in the mouse kidney [16, 17] .
It is uncertain how the alteration in luminal pH affects the toxicity of Cd-MT. It is generally believed that Cd-MT enters the cell as Cd-MT and dissociates into Cd 2+ in the cytoplasm. An alteration in luminal pH will mainly affect the phenomenon in the lumen. Therefore, a conformational change in Cd-MT in the luminal space by an increase in pH reduces the transport of luminal Cd-MT into the cell. It is also possible that carrier protein of Cd-MT in the apical membrane might be reduced in its activ- ity by an increase in luminal pH. It is reported that endocytosis of Cd-MT is mediated by megalin [18, 19] and that the expression of megalin is reduced by Cd-MT exposure [20] . However, the influence of intracellular pH on activity of megalin was not reported. Another possibility is that the increase in luminal pH directly enhances glucose transporter activity. We think that this may not be true because we have some preliminary data that ⌬ Vt glu was maintained at a similar level for at least 20 min when Cd-MT was not added to pH 6.8 and 7.7 solutions.
We found that modifiers or modulators of cytoskeleton (such as colchicine, cytochalasin D) and rho-kinase inhibitor Y-27632 prevented Cd-MT-induced functional damage. This may be compatible with the finding that endocytosis was reduced in renal tubular cells from Cdtreated animals [21] . It was reported that inhibition of acidic endocytotic compartments by chloroquine, or LY294002, prevented Cd-MT-induced apoptosis [22] . Alkalinization of luminal fluid may secondarily alter intracellular pH, which subsequently affects the endosomal uptake of Cd/Cd-MT. We also found that the time needed to reduce ⌬ Vt glu after addition of luminal Cd-MT was slightly but significantly increased in the HEPES buffer solution than in a bicarbonate buffer solution of similar pH. The reason for this difference is uncertain at the present time. HEPES is not membrane-permeable and is less likely to affect intracellular pH than bicarbonate, which may affect the results. It may suggest the existence of other factor(s) besides pH contributing to the Cd-MT-induced damage.
Based on the in vitro data as discussed above, we propose that the inhibition of CA would be a therapeutic option for the prevention of Cd-induced nephropathy. This is another important feature of this study. The in vivo experiments were designed to support this issue. Although we did not examine detailed kidney functions such as clearance studies, both plasma Cr levels and glucosuria are reasonable parameters to represent Cd nephrotoxicity. Under chronic experimental conditions in the in vivo study, we think that glucosuria is one of the parameters of nephrotoxicity rather than a simple alteration in the cotransporter. The data clearly support the notion that administration of ACZ prevents Cd-induced nephrotoxicity in a dose-dependent manner. Our in vivo data are compatible with the findings of a previous article by Nomiyama et al. [10] , although their interpretation of this effect was somewhat different. CA inhibitors are mainly used as diuretics, but not commonly used in the prevention of nephrotoxicity. From this point of view, the present data are unique. We also found that urinary excretion of Cd-MT increased by a high dose of ACZ, which supports the relationship between in vivo and in vitro data. A low dose of ACZ did not increase Cd-MT excretion. We think that this model of chronic intoxication excreted a very large amount of Cd-MT into the urine, and the low dose of ACZ may not be enough for in vivo treatment. We have previously reported that alkalinization of systemic pH by addition of citrate prevented cyclosporine-A-induced distal renal tubular acidosis in rats [23] . ACZ might also be used to prevent cyclosporine-A-induced damage.
Nomiyama et al. [10] previously reported in the rabbit that nephrotoxicity by systemic Cd exposure was also prevented by the addition of glycyrrhizic acid, the active pharmacological ingredient of licorice. They speculated that glycyrrhizic acid prevented the release of Cd-MT from the liver into the systemic circulation because of its protective effect on hepatic functions. Glycyrrhizic acid, however, was also reported to cause pseudo-aldosteronism, which subsequently causes metabolic alkalosis [24] . Therefore, it is necessary to examine whether the effect of glycyrrhizic acid was due to an increase in systemic pH by the drug.
Recently, it was reported that expression of NHE3 protein decreased while CA IV was unchanged in brush border membrane vesicles from renal proximal tubule cells in Cd-intoxicated rats. These results indicate that urinary alkalinization will occur in Cd intoxication [25] . We did not evaluate Na-H exchanger activity in this study. Because our finding indicates that alkalinization of luminal fluid prevented the Cd-MT-induced toxicity, the reduction in NHE3 protein may be an adaptive response of the kidney to prevent the damage to the proximal tubule cells.
In summary, we found for the first time that the impairment of sodium-dependent glucose transporter activity caused by luminal Cd-MT is influenced by luminal pH and that an increase in pH prevented the impairment in isolated perfused rabbit proximal tubules. We also found that inhibition of luminal CA activity, which increases the luminal pH, also prevented impairment. Addition of cytoskeleton modifiers also prevented toxicity. Furthermore, administration of ACZ in vivo also prevented the nephrotoxicity of Cd exposure. These results may point to new therapy options in preventing the nephrotoxicity of systemic Cd exposure.
